232 related articles for article (PubMed ID: 2160085)
1. Influence of hypoxia on 5-lipoxygenase pathway in rat alveolar macrophages.
Ohwada A; Kira S; Yamashita T
Prostaglandins Leukot Essent Fatty Acids; 1990 Jan; 39(1):69-73. PubMed ID: 2160085
[TBL] [Abstract][Full Text] [Related]
2. Metabolism of arachidonic acid through the 5-lipoxygenase pathway in normal human peritoneal macrophages.
Laviolette M; Carreau M; Coulombe R; Cloutier D; Dupont P; Rioux J; Braquet P; Borgeat P
J Immunol; 1988 Sep; 141(6):2104-9. PubMed ID: 2844895
[TBL] [Abstract][Full Text] [Related]
3. Comparison of 5- and 15-lipoxygenase activities in blood and alveolar leukocyte preparations from normal subjects and patients with eosinophilia.
Laviolette M; Picard S; Braquet P; Borgeat P
Prostaglandins Leukot Med; 1986 Aug; 23(2-3):191-9. PubMed ID: 3020586
[TBL] [Abstract][Full Text] [Related]
4. Modulation of alveolar macrophage-derived 5-lipoxygenase products by the sulfhydryl reactant, N-ethylmaleimide.
Peters-Golden M; Shelly C
J Biol Chem; 1987 Aug; 262(22):10594-600. PubMed ID: 3112148
[TBL] [Abstract][Full Text] [Related]
5. Arachidonic acid metabolism in bovine alveolar macrophages. Effect of calcium ionophore on lipoxygenase products.
Taylor SM; Liggitt HD; Laegreid WW; Silflow R; Leid RW
Inflammation; 1986 Jun; 10(2):157-65. PubMed ID: 3011669
[TBL] [Abstract][Full Text] [Related]
6. Pulmonary intravascular macrophages metabolize arachidonic acid in vitro. Comparison with alveolar macrophages.
Bertram TA; Overby LH; Danilowicz R; Eling TE; Brody AR
Am Rev Respir Dis; 1988 Oct; 138(4):936-44. PubMed ID: 2849345
[TBL] [Abstract][Full Text] [Related]
7. Selective inhibition of 5-lipoxygenase pathway in rat pulmonary alveolar macrophages by cigarette smoking.
Mobley A; Tanizawa H; Iwanaga T; Tai CL; Tai HH
Biochim Biophys Acta; 1987 Apr; 918(2):115-9. PubMed ID: 3030439
[TBL] [Abstract][Full Text] [Related]
8. Studies on the release of leukotrienes and histamine by human lung parenchymal and bronchial fragments upon immunologic and nonimmunologic stimulation. Effects of nordihydroguaiaretic acid, aspirin, and sodium cromoglycate.
Salari H; Borgeat P; Fournier M; Hebert J; Pelletier G
J Exp Med; 1985 Dec; 162(6):1904-15. PubMed ID: 2415659
[TBL] [Abstract][Full Text] [Related]
9. Amplification of LTB4 generation in AM-PMN cocultures: transcellular 5-lipoxygenase metabolism.
Grimminger F; Sibelius U; Seeger W
Am J Physiol; 1991 Aug; 261(2 Pt 1):L195-203. PubMed ID: 1651667
[TBL] [Abstract][Full Text] [Related]
10. Characterization of leukotriene A4 and B4 biosynthesis.
Jakschik BA; Kuo CG
Prostaglandins; 1983 Jun; 25(6):767-82. PubMed ID: 6312489
[TBL] [Abstract][Full Text] [Related]
11. Enhanced 5-lipoxygenase activity in lung macrophages compared to monocytes from normal subjects.
Bigby TD; Holtzman MJ
J Immunol; 1987 Mar; 138(5):1546-50. PubMed ID: 3027181
[TBL] [Abstract][Full Text] [Related]
12. Kinetics of leukotriene A4 synthesis by 5-lipoxygenase from rat polymorphonuclear leukocytes.
Wiseman JS; Skoog MT; Nichols JS; Harrison BL
Biochemistry; 1987 Sep; 26(18):5684-9. PubMed ID: 2823886
[TBL] [Abstract][Full Text] [Related]
13. Production of 5-lipoxygenase pathway metabolites by peripheral leucocytes in capillary leak syndrome (Clarkson disease).
Rondeau E; Sraer J; Bens M; Doleris LM; Lacave R; Sraer JD
Eur J Clin Invest; 1987 Feb; 17(1):53-7. PubMed ID: 3032644
[TBL] [Abstract][Full Text] [Related]
14. Decreased leukotriene B4 synthesis in smokers' alveolar macrophages in vitro.
Laviolette M; Coulombe R; Picard S; Braquet P; Borgeat P
J Clin Invest; 1986 Jan; 77(1):54-60. PubMed ID: 3003154
[TBL] [Abstract][Full Text] [Related]
15. Guinea pig alveolar eosinophils and macrophages produce leukotriene B4 but no peptido-leukotriene.
Hirata K; Maghni K; Borgeat P; Sirois P
J Immunol; 1990 Mar; 144(5):1880-5. PubMed ID: 2155267
[TBL] [Abstract][Full Text] [Related]
16. Enzymes functional in the syntheses of leukotrienes and related compounds.
Shimizu T
Int J Biochem; 1988; 20(7):661-6. PubMed ID: 2846379
[TBL] [Abstract][Full Text] [Related]
17. 1-[4-[3-[4-[bis(4-fluorophenyl)hydroxymethyl]-1- piperidinyl]propoxy]-3-methoxyphenyl]ethanone(AHR-5333): a selective human blood neutrophil 5-lipoxygenase inhibitor.
Graff G; Anderson LA
Prostaglandins; 1989 Oct; 38(4):473-96. PubMed ID: 2554366
[TBL] [Abstract][Full Text] [Related]
18. Phorbol myristate acetate and the calcium ionophore A23187 synergistically induce release of LTB4 by human neutrophils: involvement of protein kinase C activation in regulation of the 5-lipoxygenase pathway.
Liles WC; Meier KE; Henderson WR
J Immunol; 1987 May; 138(10):3396-402. PubMed ID: 3033073
[TBL] [Abstract][Full Text] [Related]
19. Stimulation of 5-lipoxygenase activity in polymorphonuclear leukocytes of rats by caseinate treatment.
Chang WC; Su GW
Biochem Pharmacol; 1987 Sep; 36(18):3033-6. PubMed ID: 2820429
[TBL] [Abstract][Full Text] [Related]
20. Auranofin stimulates LTA hydrolase and inhibits 5-lipoxygenase/LTA synthase activity of isolated human neutrophils.
Betts WH; Hurst NP; Murphy GA; Cleland LG
Biochem Pharmacol; 1990 Apr; 39(7):1233-7. PubMed ID: 2157444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
